Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company") ...
Renowned artist "Baiyu" Bo-Xi Lin met with aging wine underwater at the Venice Biennale, blending art and fine wine. The solo exhibition of renowned artist "Baiyu" Bo-Xi Lin is being held at the Venic ...
BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world's first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI IP, and Frontgrade Gaisler, a leading ...
SYDNEY, AUSTRALIA / ACCESSWIRE / May 4, 2024 / KOSEC - Kodari Securities has announced the launch of Buffett 2.0, a revolutionary valuation model poised to reshape investment analysis and the equities ...
LONDON, ENGLAND / ACCESSWIRE / May 4, 2024 / Interlend Holdings is one of the most well-known brokers in the country with over 2.5$ billion dollars in assets under management, attracting a wide range ...
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology ...
Loop Media, Inc. ("Loop Media" or "our" or the "Company") (NYSE American: LPTV), a leading multichannel streaming CTV platform that provides curated music videos ...
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the ...
NEW YORK, May 3, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers ...
A transformational moment in Puig's 110-year-old history Puig Brands, S.A. ("Puig" or the "Company"), the global player in Premium Beauty with a diversified footprint across brands, product categories ...
Revenue Increased 10% to $46.5 Million ENGLEWOOD, Colo., April 30, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture ...
Total revenues were $2.36 billion, above the midpoint of the guidance range of $2.30 billion +/- $125 million; GAAP diluted EPS attributable to KLA was $4.43 and non-GAAP diluted EPS attributable to ...